Igor K.
- Country
- Czechia
- Department
- Klinika komplexní onkologické péče
Research Overview
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Phase 3 Randomized Study of Adagrasib and Cetuximab Versus Chemotherapy in Advanced Colorectal Cancer with KRAS G12C Mutation Post-First-Line Therapy
- Phase 3 Evaluation of Trastuzumab Deruxtecan and Rilvegostomig Versus Standard Chemotherapy in HER2-Expressing Advanced Biliary Tract Cancer
Data & Insights
Has run more than one trial at 69 of 228 partner sites.
Specializations
Colorectal Cancer Research
The investigator specializes in studying advanced therapeutic approaches for colorectal cancer, with particular emphasis on cases involving KRAS G12C mutations.
- Advanced-stage colorectal cancer treatment
- Targeted molecular therapy
- Second-line treatment strategies
Their research explores combination therapeutic approaches using targeted agents and established treatments for improved patient outcomes.
Precision Oncology
The investigator focuses on mutation-specific treatment approaches, particularly in the context of KRAS-mutated cancers. Their work involves evaluating novel therapeutic combinations.
- Molecular targeting strategies
- Biomarker-driven therapy
- Personalized treatment approaches
Their expertise extends to developing targeted treatment strategies for specific genetic alterations in cancer.
Combination Therapy Development
The investigator specializes in studying combination treatment approaches, particularly the integration of targeted therapies with conventional treatments.
- Novel drug combinations
- Treatment optimization
- Therapeutic resistance management
Their research evaluates innovative therapeutic combinations to enhance treatment efficacy in advanced cancer cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.